your market intelligence analyst
Search Results
919 results
Your search is now limited to «AstraZeneca» expert search.
Motley Fool 09/25/2020 16:15
Canada is the latest country to enter a big vaccine-delivery commitment with AstraZeneca.
More from Motley Fool:
FDLI SmartBrief 09/25/2020 12:47
The FDA has not given AstraZeneca permission to resume clinical testing in the US of a COVID-19 vaccine candidate developed at the University of Oxford.
More from FDLI SmartBrief:
CNBC 09/25/2020 08:03
The stocks making the biggest moves in premarket trading include Costco, AstraZeneca, Novavax, Harley-Davidson & more.
More from CNBC:
FiercePharmaManufacturing 09/25/2020 06:00
AstraZeneca, Samsung reach $331M biologics manufacturing deal amid Korean CMO's expansion push Samsung Biologics won a $331 million deal to produce drug products to support AstraZeneca’s biologics therapeutics.
More from FiercePharmaManufacturing: 09/25/2020 03:07
AstraZeneca gets partial immunity in low-cost EU vaccine deal.
More from
TRT World 09/25/2020 02:50
AstraZeneca has secured the European Union's backing in a confidential agreement which reflects the lower price sought by the British drugmaker, an EU official said.
More from TRT World:
Malay Mail Online 09/24/2020 21:20
Reuters pic LONDON, Sept 25 ― London shares dropped yesterday, hitting session lows after Britain scaled-back job support for workers hit by the resurgent coronavirus pandemic, while AstraZeneca slid as US trials for its Covid-19 vaccine remained on hold.
More from Malay Mail Online:
BioPharma Dive 09/24/2020 11:42
AstraZeneca turns to Samsung Biologics to help fuel Asia drugs push.
More from BioPharma Dive:
FoxBusiness 09/24/2020 09:26
AstraZeneca waiting for FDA to greenlight restart of US drug trial.
More from FoxBusiness:
Hindu Business Line (India) 09/24/2020 05:42
The US trial of AstraZeneca's Covid-19 vaccine candidate, initially developed by the University of Oxford, remains on hold while regulators investigate an illness in one of the participants, even after a British study and other programmes outside of the ...
More from Hindu Business Line (India):
Fortune 09/24/2020 05:35
Pascal Soriot, the chief executive of pharmaceutical giant AstraZeneca, has defended his company’s transparency amid criticism it has not been forthcoming enough about safety concerns that led to a pause in testing its COVID-19 vaccine.
More from Fortune:
Channel NewsAsia (Singapore) 09/24/2020 05:26
The US trial of AstraZeneca's COVID-19 vaccine candidate, initially developed by the University of Oxford, remains on hold while regulators investigate an illness in one of the participants, even after a British study and other programmes outside of the ...
More from Channel NewsAsia (Singapore): 09/24/2020 04:46
Pune, Maharashtra, India, September 24 2020 (Wiredrelease) MarketResearch.Biz –:The recent report posted via MarketResearch.Biz on Dry Powder Inhaler market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market. Global Dry Powder Inhaler Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements...
More from (India) 09/24/2020 04:18
AstraZeneca is still waiting for the goahead from the U.S. drug regulator to restart the clinical trial of its potential COVID19 vaccine in the United States, Chief Executive Pascal Soriot said on Thursday.
More from (India):
BioPharma-Reporter 09/24/2020 04:08
A spokesperson for AstraZeneca told us: “Regulators in each individual country determine when trials can start and they do this in their own time frame.
More from BioPharma-Reporter:
Economic Times (India) 09/23/2020 13:52
Alex Azar said that the FDA's investigation, which has continued even after the trial has resumed outside of the United States, shows that the agency takes safety of the vaccine seriously.
More from Economic Times (India):
CNBC - Business 09/23/2020 11:02
AstraZeneca launched its late-stage trials at the end of August and is one of at least four vaccine candidates, along with Pfizer's and Moderna's, in late-stage trials.
More from CNBC - Business:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications